Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers

We began analyzing https://link.springer.com/chapter/10.1007/978-1-4757-9613-1_15, but it redirected us to https://link.springer.com/chapter/10.1007/978-1-4757-9613-1_15. The analysis below is for the second page.

Title[redir]:
Structure of CD26 (Dipeptidyl Peptidase IV) and Function in Human T Cell Activation | SpringerLink
Description:
1996 was the 10th anniversary of the establishment of the cluster of differentiation antigen, CD26 by the Second Workshop and Conference on Human Leukocyte Differentiation Antigens1. First described as a T cell activation antigen, CD26 was found to he strongly...

Matching Content Categories {๐Ÿ“š}

  • Education
  • Science
  • Telecommunications

Content Management System {๐Ÿ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of doi.org audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {๐Ÿ’ธ}

We don't see any clear sign of profit-making.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {๐Ÿ”}

google, scholar, cell, cas, journal, immunology, human, article, schlossman, morimoto, peptidase, activation, dipeptidyl, cells, chapter, pubmed, kameoka, antigen, deaminase, surface, hegen, expression, adenosine, dang, function, molecule, tanaka, torimoto, privacy, cookies, content, information, publish, cellular, dong, medicine, role, involved, access, download, biological, springer, search, immune, martin, book, experimental, activity, protein, preview,

Topics {โœ’๏ธ}

solid-phase immobilized anti-1f7 anti-if7 monoclonal antibody month download article/chapter mouse thymocyte-activating molecule mitogen-activated protein kinase hiv infection 8 membrane-anchoring domain proline-dependent structural dipeptidyl peptidase iv privacy choices/manage cookies terminal signal sequence dipetidyl peptidase iv antigen-specific cd4+ device instant download leukocyte typing iv receptor-mediated uptake chapter cellular peptidases martin luther university von dem borne leukocyte typing ii protein tyrosine kinases protein tyrosine phosphatases antigen rective memory cell activation antigen european economic area subsequent work showed severe combined immunodeficiency neo-plastic progression distinct epitopes recognized fcr-mediated crosslinking key costimulatory molecule surface protease involved download preview pdf conditions privacy policy diseases martin hegen cell surface ectopeptidase cell surface modulation harvard medical school oxford university press rui-ping dong activated nk cells mononuclear blood cells cells arc defined accepting optional cookies journal finder publish check access human lupus nephritis tcr-cd3 complex ethics access chikao morimotoย &ย stuart

Schema {๐Ÿ—บ๏ธ}

ScholarlyArticle:
      headline:Structure of CD26 (Dipeptidyl Peptidase IV) and Function in Human T Cell Activation
      pageEnd:116
      pageStart:109
      image:https://media.springernature.com/w153/springer-static/cover/book/978-1-4757-9613-1.jpg
      genre:
         Biomedical and Life Sciences
         Biomedical and Life Sciences (R0)
      isPartOf:
         name:Cellular Peptidases in Immune Functions and Diseases
         isbn:
            978-1-4757-9613-1
            978-1-4757-9615-5
         type:Book
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Martin Hegen
            affiliation:
                  name:Harvard Medical School
                  address:
                     name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Junichi Kameoka
            affiliation:
                  name:Harvard Medical School
                  address:
                     name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rui-Ping Dong
            affiliation:
                  name:Harvard Medical School
                  address:
                     name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chikao Morimoto
            affiliation:
                  name:Harvard Medical School
                  address:
                     name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stuart F. Schlossman
            affiliation:
                  name:Harvard Medical School
                  address:
                     name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      keywords:Tyrosine Phosphorylation, Adenosine Deaminase, Dipeptidyl Peptidase, Severe Combine Immunodeficiency Disease, Induce Tyrosine Phosphorylation
      description:1996 was the 10th anniversary of the establishment of the cluster of differentiation antigen, CD26 by the Second Workshop and Conference on Human Leukocyte Differentiation Antigens1. First described as a T cell activation antigen, CD26 was found to he strongly expressed on subsets of both activated CD4 and CD8 T cells2. Subsequent work showed the expression of CD26 on activated Nk cells, B cells and B cell lines and demonstrated CD26 expression on a variety of different cell types, most abundantly on epithelia of the intestine, prostate and the proximal tubuli of the kidneys3,4,5. Furthermore, it was demonstrated that CD26 possesses enzymatic activity, dipeptidyl peptidase IV (DPP IV; EC 3.4.14.5), in its extracellular domain4 and is identical to the previously described adenosine deaminase (ADA, EC 3.5.4.4) binding protein6,7. Recent studies indicate that CD26 plays a seminal role in T cell costimulation and may be involved in severe combined immunodeficiency and HIV infection 8,9.
      datePublished:1997
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
      context:https://schema.org
Book:
      name:Cellular Peptidases in Immune Functions and Diseases
      isbn:
         978-1-4757-9613-1
         978-1-4757-9615-5
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Harvard Medical School
      address:
         name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Harvard Medical School
      address:
         name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Harvard Medical School
      address:
         name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Harvard Medical School
      address:
         name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Harvard Medical School
      address:
         name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Martin Hegen
      affiliation:
            name:Harvard Medical School
            address:
               name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Junichi Kameoka
      affiliation:
            name:Harvard Medical School
            address:
               name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Rui-Ping Dong
      affiliation:
            name:Harvard Medical School
            address:
               name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Chikao Morimoto
      affiliation:
            name:Harvard Medical School
            address:
               name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Stuart F. Schlossman
      affiliation:
            name:Harvard Medical School
            address:
               name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
      name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
      name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
      name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
      name:Division of Tumor Immunology Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {๐Ÿ”—}(143)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Clipboard.js

Emails and Hosting {โœ‰๏ธ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
4.64s.